Lv21
110 积分 2025-06-21 加入
Impact of Belzutifan on Pancreatic Cystic Lesions and Neuroendocrine Tumors in Patients with Von Hippel-Lindau Disease
3小时前
求助中
FDA fast-track approval of belzutifan is a milestone in rare cancer therapy
3小时前
已完结
Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease
4小时前
已完结
Belzutifan in Europe: A New Targeted Therapy for Clear Cell Renal Cancer
4小时前
已完结
Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study
4小时前
已完结
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study
4小时前
已完结
Rapid Cardiovascular Response to Belzutifan in HIF2A -Mediated Paraganglioma
4小时前
已完结
Belzutifan is active in VHL-related cancers
4小时前
已完结
Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study
4小时前
已完结
Belzutifan for Advanced Pheochromocytoma or Paraganglioma
4小时前
已完结
皖公网安备34019202002308
